ReviewAmerican journal of human genetics2026

Implications of the FDA's new plausible mechanism framework for the development of a personalized in vivo prime editing platform.

Emily R Feierman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.